1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses
← catalyst calendarSponsored by Bausch & Lomb Incorporated (industry) · BLCO — their whole pipeline →.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Na · None · Other
Enrollment
32actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-25
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-10-04 | actual | When the study began enrolling |
| Primary completion | 2023-12-15 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2023-12-15 | actual | The whole study's end, after follow-up |
| First posted | 2023-09-26 | actual | When this record first appeared on the registry |
| Results posted | 2026-08-25 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-08-25 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Refractive Ametropia
- Astigmatism
Intervention
- Device: REVIVE Toric Soft Contact Lenses — also filed as REVIVE™ (hioxifilcon D)
Primary outcome
what the primary-completion date above is the date OFMean logMAR Visual Acuity at 6m
measured 1-Week Follow-up Visit (approximately 7 ± 3 days after the dispensing visit)
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2023-09-08 · 1005 KB · Prot_SAP_000.pdf
Related
BLCO's other studiesmost recently updated first
- Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact Lenses Not applicable · Completed
- BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution Trial Phase 2 · Not yet recruiting
- 1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for Presbyopia Not applicable · Completed
- Surface Refractive Index Shift of Kalifilcon A Compared With Dailies Total1 and Precision1 Lenses Not applicable · Completed
- Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension Phase 2 · Completed
Permalink · BLCO's whole pipeline · Catalyst calendar · Every registered study · What changed